TABULA BIO

Tabula Bio is a stealth-mode startup operating at the intersection of artificial intelligence, molecular biology, and consumer health. We are developing advanced tools that apply cutting-edge machine learning to genomic and biomedical data with the goal of delivering more accurate, personalized insights.

Our current focus is on enhancing predictive models for complex, highly heritable conditions such as autism and schizophrenia — areas where traditional approaches have reached their limits. By integrating multi-scale biological signals with modern AI techniques, we aim to close the gap between genetic data and actionable understanding.

While our work is currently under active development, our long-term mission is to make sophisticated genomic intelligence accessible, ethical, and impactful at scale.

Tabula Bio is headquartered in the United States and is preparing to launch its first consumer-facing product in 2025.